Get Live Data

The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

  2. Share Prices
  3. Oxford Biodyn Share Price
  4. Oxford Biodyn Share News
  5. IN BRIEF: Oxford BioDynamics Covid severity tests available in US

Pin to quick picksOxford Biodyn Share News (OBD)

Oxford Biodyn Information

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.10
Bid: 8.10
Ask: 8.48
Change: -0.10 (-1.22%)
Spread: 0.38 (4.691%)
Open: 8.00
High: 8.50
Low: 8.00
Prev. Close: 8.20
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Oxford BioDynamics Covid severity tests available in US

Fri, 17th Dec 2021 20:34

Oxford BioDynamics PLC - biotechnology firm focused on discovery and development of epigenetic biomarkers - Says its EpiSwitch Covid-19 severity test is available in the US and that it has seen increased interest following the resurgence of the Delta and Omicron variants. Says EpiSwitch can identify those with the greatest risk of experiencing critical, life-threatening disease because of a SARS-Cov-2 viral infection. Oxford BioDynamics expects to launch blood-based predictive tests in early 2022.

Current stock price: 34.00 pence

Year-to-date change: down 59%

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
16 Dec 2022 21:22

TRADING UPDATES: Uniphar takeover fails; Pearson notes redemption end

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
25 Oct 2022 20:58

TRADING UPDATES: Mobile Streams sees sales multiply; Corcel gets funds

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
7 Oct 2022 19:51

TRADING UPDATES: Allied Minds eyes delisting; Tertiary completes sale

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
7 Oct 2022 12:57

Oxford Biodynamics raises £9.1m in placing

(Sharecast News) - Biotech company Oxford BioDynamics said on Friday that it has conditionally raised around £9.1m in a placing to accelerate the commercialisation of a cancer test.

Read more
3 Oct 2022 11:52

IN BRIEF: Oxford BioDynamics up on US reimbursement code for EpiSwitch

Oxford BioDynamics PLC - Oxford-based biotechnology firm focused on discovery and development of epigenetic biomarkers Says its US reimbursement code for EpiSwitch is now available. EpiSwitch Checkpoint-inhibitor Response Test is a test which predicts a patient's likely response to immune checkpoint inhibitor therapy. It was first launched in the US in February.

Read more
5 Jul 2022 15:48

IN BRIEF: Oxford BioDynamics wins US reimbursement code for EpiSwitch

Oxford BioDynamics PLC - Oxford-based biotechnology firm focused on discovery and development of epigenetic biomarkers - Issued a proprietary laboratory code by the American Medical Association's Current Procedural Terminology Editorial Board. The code was issued for the EpiSwitch Checkpoint-inhibitor Response Test, a test which predicts a patient's likely response to immune checkpoint inhibitor therapy.

Read more
28 Jun 2022 11:09

Oxford BioDynamics shares drop as it might need funding by early 2023

(Alliance News) - Oxford BioDynamics PLC on Tuesday said it will need additional funding - either internal or external - by early 2023, as it posted a sharp drop in half-year revenue, sending its shares tumbling.

Read more
21 Jun 2022 16:04

UK earnings, trading statements calendar - next 7 days

Wednesday 22 June 
Berkeley Group Holdings PLCFull Year Results
Liontrust Asset Management PLCFull Year Results
Micro Focus International PLCHalf Year Results
Thursday 23 June 
DeepVerge PLCFull Year Results
First Property Group PLCFull Year Results
Manolete Partners PLCFull Year Results
Naked Wines PLCFull Year Results
Oxford Metrics PLCHalf Year Results
Redx Pharma PLCHalf Year Results
Serco Group PLCTrading Statement
Volex PLCFull Year Results
XPS Pensions Group PLCFull Year Results
Friday 24 June 
On the Beach Group PLCHalf Year Results
Monday 27 June 
Cake Box Holdings PLCFull Year Results
NextEnergy Solar Fund LtdFull Year Results
Polar Capital Holdings PLCFull Year Results
Tuesday 28 June 
Appreciate Group PLCFull Year Results
Biffa PLCFull Year Results
ICG Enterprise Trust PLCQ1 Results
IG Design Group PLCFull Year Results
Oxford BioDynamics PLCHalf Year Results
Petrofac LtdTrading Statement
Wise PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
21 Jun 2022 11:45

AIM WINNERS & LOSERS: K3 Capital upbeat; Morses sinks after warning

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
21 Jun 2022 10:47

Oxford Biodynamics shares jump as CiRT blood test available in UK

(Alliance News) - Oxford BioDynamics PLC shares rose on Tuesday on news that the biotechnology firm's checkpoint inhibitor response test is now available in the UK.

Read more
8 Apr 2022 15:01

DIRECTOR DEALINGS: PCA to Bellway chair buys GBP500,000 in shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and not separately reported by Alliance News:

Read more
3 Mar 2022 15:26

DIRECTOR DEALINGS: Hyve chair and CEO buy as share price hit by Russia

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News:

Read more
25 Feb 2022 20:12

TRADING UPDATES: Tintra faces sale delay; Seplat makes acquisition

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
25 Jan 2022 18:06

IN BRIEF: Oxford BioDynamics loss widens; says well placed for 2022

IN BRIEF: Oxford BioDynamics loss widens; says well placed for 2022

Read more
18 Jan 2022 16:10

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
12345678

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.